Cytosorbents (CTSO) Depreciation & Amortization (CF) (2010 - 2026)
Cytosorbents (CTSO) reported Depreciation & Amortization (CF) of $289000.0 for Q1 2026, down 21.57% on a YoY basis from $368503.0 in Q1 2025, and up 197.94% quarter-over-quarter from $97000.0 in Q4 2025.
Cytosorbents (CTSO) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Cytosorbents has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $289000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 21.57% year-over-year to $289000.0; the trailing twelve-month figure through Mar 2026 stood at -$382000.0 (down 46.08% YoY), and the FY2025 full-year result was $1.2 million, down 7.57% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $289000.0, up from $97000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $407208.0 in Q3 2023, with the low at -$404000.0 in Q2 2025.
- Historically, Depreciation & Amortization (CF) has averaged $123263.3 across 5 years, with a median of $223214.0 in 2022.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 91.11% — and 2024, when it tumbled 199.76%.
- Cytosorbents' Depreciation & Amortization (CF) stood at $223214.0 in 2022, then surged by 75.29% to $391269.0 in 2023, then plunged by 60.64% to $154000.0 in 2024, then plunged by 37.01% to $97000.0 in 2025, then soared by 197.94% to $289000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $289000.0 (Q1 2026), $97000.0 (Q4 2025), and -$364000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | 289,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 289,000.00 |
| Mar 31, 2026 | 289,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | -364,000.00 |
| Sep 30, 2025 | -364,000.00 |
| Jun 30, 2025 | -404,000.00 |
| Jun 30, 2025 | -404,000.00 |
| Mar 31, 2025 | 368,503.00 |
| Mar 31, 2025 | 368,503.00 |
| Dec 31, 2024 | 154,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | -383,000.00 |
| Sep 30, 2024 | -383,000.00 |
| Jun 30, 2024 | -401,000.00 |
| Jun 30, 2024 | -401,000.00 |
| Mar 31, 2024 | 397,286.00 |
| Mar 31, 2024 | 397,286.00 |
| Dec 31, 2023 | 391,269.00 |
| Dec 31, 2023 | 391,269.00 |